Ms. Robin L.
Washington is a Chief Development Officer at Catalyst Partners Acquisition Corp., an Independent Director at Alphabet, Inc., a Co-President, CFO, COO & Director at Salesforce, Inc., an Advisor at Beacon Biosignals, Inc., an Advisory Board at Altas Corp, a Chief Operating & Financial Officer & Co-President at Salesforce UK Ltd., a Managing Director at Gilead Sciences GmbH, a Member-Presidents Council at University of Michigan and a Member-Visitors Board at Graziadio School of Business & Management.
She is on the Board of Directors at StockX LLC, The MasterCard Foundation, Alphabet, Inc., Salesforce, Inc., Gilead Sciences International Ltd., Children's Discovery Museum, Gilead Sciences Europe Ltd., Kite Pharma UK Ltd., UCSF Benioff Children's Hospital Oakland, Vertiv Group Corp., vertiv, Inc. and Financial Accounting Foundation.
Ms. Washington was previously employed as an Independent Director by Eikon Therapeutics, Inc., an Independent Director by Vertiv Holdings Co., a Chief Financial Officer by Kite Pharma, Inc., an Independent Director by Honeywell International, Inc., a Chief Financial Officer by Pharmasset, Inc., a CFO, Chief Accounting Officer & Executive VP by Gilead Sciences, Inc., an Independent Director by MIPS Technologies, Inc., a Chief Financial Officer by Hyperion Solutions Corp., a Senior Vice President & Controller by PeopleSoft, Inc., a Senior Auditor by Deloitte & Touche LLP, an Accounting Analyst by Federal Reserve Bank of Chicago, and a Finance Director by Tandem Computers, Inc. She also served on the board at Tektronix, Inc., Gilead Connecticut, Inc. and Gilead Sciences Ltd. She received her undergraduate degree from the University of Michigan and an MBA from Pepperdine University.